{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:39:11Z","timestamp":1793047151990,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":448,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jtct.2021.11.022","type":"journal-article","created":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T10:51:42Z","timestamp":1638615102000},"page":"172.e1-172.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Post-Transplantation Immunosuppression After TCR\u0391\u03b2\/CD19 Graft Depletion Does Not Improve HSCT Outcomes in Primary Immunodeficiency"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2354-2588","authenticated-orcid":false,"given":"Alexandra","family":"Laberko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5962-1264","authenticated-orcid":false,"given":"Aishat","family":"Idarmacheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6607-1384","authenticated-orcid":false,"given":"Svetlana","family":"Glushkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6148-7209","authenticated-orcid":false,"given":"Dmitry","family":"Pershin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Shelikhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maschan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei","family":"Maschan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Balashov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2021.11.022_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100792","article-title":"Graft-versus-host disease prophylaxis: Pathophysiology-based review on current approaches and future directions","volume":"48","author":"Martinez-Cibrian","year":"2021","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtct.2021.11.022_bib0002","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2014-03-563817","article-title":"HLA-haploidentical stem cell transplantation after removal of\u00a0+\u00a0T and B cells in children with nonmalignant disorders","volume":"124","author":"Bertaina","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2021.11.022_bib0003","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jaci.2017.07.008","article-title":"T-cell receptor \u03b1\u03b2\u00a0+\u00a0and CD19\u00a0+\u00a0cell\u2013depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency","volume":"141","author":"Shah","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jtct.2021.11.022_bib0004","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10875-019-00648-x","article-title":"Use of TCR \u03b1+\u03b2+\/CD19+\u2013depleted haploidentical hematopoietic stem cell transplant is a viable option in patients with primary immune deficiency without matched sibling donor","volume":"39","author":"Brettig","year":"2019","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jtct.2021.11.022_bib0005","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood.2019001757","article-title":"Mismatched related vs matched unrelated donors in TCR\u03b1\u03b2\/CD19-depleted HSCT for primary immunodeficiencies","volume":"134","author":"Laberko","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.11.022_bib0006","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bbmt.2016.12.635","article-title":"Risk factors for and the clinical impact of cytomegalovirus and Epstein-Barr virus infections in pediatric recipients of TCR-\u03b1\/\u03b2\u2013 and CD19-depleted grafts","volume":"23","author":"Laberko","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"S1","key":"10.1016\/j.jtct.2021.11.022_bib0007","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41409-020-01120-w","volume":"55","author":"Laberko","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.11.022_bib0008","unstructured":"U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE), version 5.0. Available at https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf. Accessed 08.10.2019."},{"key":"10.1016\/j.jtct.2021.11.022_bib0009","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/sj.bmt.1703015","article-title":"Engraftment syndrome following hematopoietic stem cell transplantation","volume":"27","author":"Spitzer","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.11.022_bib0010","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/sj.bmt.1702639","article-title":"Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities","volume":"26","author":"Furlong","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.11.022_bib0011","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/s41409-020-01128-2","article-title":"T-cell tracking, safety, and effect of low-dose donor memory T-cell infusions after \u03b1\u03b2 T cell-depleted hematopoietic stem cell transplantation","volume":"56","author":"Blagov","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2021.11.022_bib0012","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/S2352-3026(15)00045-9","article-title":"Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis","volume":"2","author":"Admiraal","year":"2015","journal-title":"Lancet Haematol"},{"issue":"1","key":"10.1016\/j.jtct.2021.11.022_bib0013","doi-asserted-by":"crossref","first-page":"e13594","DOI":"10.1111\/petr.13594","article-title":"Control of graft-versus-host disease with rabbit anti-thymocyte globulin, rituximab, and bortezomib in TCR\u03b1\u03b2\/CD19-depleted graft transplantation for leukemia in children: a single-center retrospective analysis of two GVHD-prophylaxis regimens","volume":"24","author":"Shekhovtsova","year":"2020","journal-title":"Pediatr Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2021.11.022_bib0014","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jtct.2021.01.010","article-title":"Serotherapy-free regimen improves non-relapse mortality and immune recovery among the recipients of \u03b1\u03b2 T cell\u2013depleted haploidentical grafts: retrospective study in childhood leukemia","volume":"27","author":"Shelikhova","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2021.11.022_bib0015","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/s41409-021-01378-8","article-title":"EBMT\/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity","volume":"56","author":"Lankester","year":"2021","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721014093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721014093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:03:44Z","timestamp":1763003024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636721014093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2666636721014093"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2021.11.022","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-Transplantation Immunosuppression After TCR\u0391\u03b2\/CD19 Graft Depletion Does Not Improve HSCT Outcomes in Primary Immunodeficiency","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2021.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}